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INTRODUCTION
Glaucoma is the second leading cause of blindness in human eye. It is a disease of the optic nerve, which leads to optic disc excavation with death of a substantial number of retinal ganglion cells in the inner retina and loss of their axons in the optic nerve, with consequent vision loss and, in severe 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 old has glaucoma with loss of visual function, corresponding to 60 million people worldwide being affected and more than 8 million being bilaterally blind [1] . In developed countries, an additional 50% of people are affected by glaucoma but are not aware of their disease, and in the developing countries the awareness is even lower [2] . Glaucoma is the second leading cause of vision loss in the world, and improved methods of screening and therapies for its treatment are urgently needed [2] .
The primary reason of glaucoma (its main risk factor) is the abnormality of IntraOcular Pressure (IOP), the principal factor currently treatable. The adverse effects of raised IOP can be rectified by using various medical and surgical techniques, aimed at lowering IOP towards safe levels in individual patients, which can improve the eye vision to a certain extent. When this pressure is lowered by 20-40% with respect to its initial abnormal values, the average rate of progressive vision loss is halved [1] .
Three main approaches can be followed in the treatment of glaucoma: (i) medical: hypotensive eye drops reduce the production of Aqueous Humor (AH) or increase its outflow; (ii) paramedical:
Selective Laser Trabeculoplasty is able to induce a stretching of trabecular meshwork in patients not yet undergoing drug treatment; (iii) surgical: the principle of glaucoma surgery is to increase AH outflow from the eye, with consequent reduction of IOP [3] .
Surgery is used for non-responsive cases to medical treatment and it is divided into two main subcategories: (a) conventional treatments creating a link between the Anterior Chamber (AC) and the sub-conjunctival space of the eye, such as filtration procedures (trabeculectomy) or Molteno, Baerveldt, Krupin and Ahmed drainage valves [4] [5] [6] [7] [8] [9] ; (b) recent treatments creating a link between the AC and the Suprachoroidal Space (SCS), using devices such as the SOLX ® Gold Micro Shunt (GMS) and the novel Silicon Shunt Device (SSD) studied in the present work [10] [11] [12] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   J  o  u  r  n  a  l  o  f  N  u  m  e  r  i  c  a  l  M  e  t  h  o  d  s  f  o  r  H  e  a  t  a  n  d   6 This work is concerned with the second surgical sub-category, and aims at employing the generalized porous medium model to compare the fluid dynamics performance of the SOLX ® GMS and of the novel SSD, proposed by some of the authors of this work in a recent clinical study [12] .
Such a modeling study can support the surgeons to plan the surgical procedure and to choose the most effective ocular drainage device for their patients.
In a variable percentage of patients, filtration procedures and drainage valves (first surgical subcategory) lead to significant post-operative complications such as bleb leaks, hypotony, blebitis, endophthalmitis and bleb encapsulation, that indicate failure of IOP control [12] [13] [14] [15] . As a consequence, research efforts are targeted to design safe bleb-less procedures, in order to maintain long-term surgical success of all available filtration based surgical procedures.
On the other hand, the second surgical sub-category discussed previously includes bleb-less surgical approaches [10] [11] [12] , which exploit and enhance alternative AH outflow pathways. Among the devices used in these approaches, the SOLX ® GMS is a biocompatible device made of gold flat plates containing microchannels, that create a connection between the AC and the Anterior SupraChoroidal (supraciliary) Space (ASCS), increasing the uveoscleral flow, as shown in clinical studies [11, 12] . The novel SSD, that has been recently employed by some of the authors in a pilot study [12] , is a microtube made of silicon that connects the AC to the Posterior SupraChoroidal Space (PSCS). The operating principle of both shunts is based on the natural hydrostatic pressure difference between the AC and the SCS, that is the driving force of AH flow through the device. In practice, the AC pressure coincides with the IOP. The AH is evacuated from the AC through the device, and it flows through the SCS via the choroidal vascular system or by gradually flowing through the scleral layers and the conjunctiva, without the creation of blebs [12] . To the authors' knowledge, no experimental data are available in the literature on pressure gradients in human eyes,
and measured values of pressure difference between AC and SCS have been presented for cynomolgus monkeys by Emi et al. [16] . On the basis of that study, at an IOP of 15 mmHg, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 On the other hand, preliminary results for installations of the novel SSD prove a higher success rate, obtaining a 90% of patients with post-operative IOP lower than 21 mmHg without any medication [12] .
On the basis of the authors' knowledge, numerical studies comparing the fluid dynamics performance of different ocular drainage devices, by using the generalized porous medium model to analyse the interaction between the device and the surrounding tissues, are not present in the available literature. However, the need to have a clear understanding of the local phenomena that occur in the eye, also by means of a numerical modelling approach, is recognized in the scientific community [18, 19] , such as the role of porous media in biological tissues [20] . Therefore, the authors employ for the first time the generalized porous medium model to study the fluid dynamics of the GMS and of the novel SSD and the surrounding porous tissues, by using the Characteristic The paper is organized as follows: the next section presents a description of the GMS and of the novel SSD; in section 3, the governing equations are reported. In section 4, the three-dimensional fully explicit CBS scheme is briefed, in terms of temporal and spatial discretizations. Section 5
shows the results obtained and some conclusions are drawn in the last section.
DESCRIPTION OF THE TWO SHUNTS
The SOLX ® GMS is a non-valved flat-plate drainage device made of 24-K medical-grade (99.95%)
gold [11] . The GMS width, length and thickness are 2. Implantation of the GMS is typically performed under topical anaesthesia, sometimes augmented with subconjunctival lidocaine. The gold shunt can be inserted in any quadrant. It is important to select an area with healthy sclera and conjunctiva, to ensure a watertight closure and prevent bleb formation. Following the creation of a conjunctival peritomy, a 3-4 mm full thickness scleral incision is created 2-3 mm posterior to the limbus, to expose the supraciliary space. A scleral pocket at 95% depth is then fashioned, using a crescent knife to extend all of the way to the scleral spur. While the eye is still pressurized, the dissection is continued posteriorly into the suprachoroidal space. Subsequently, the anterior chamber is entered after the anterior chamber is stabilized with viscoelastic or by anterior chamber maintainer. The GMS is then delicately positioned with the proximal end in the anterior chamber and the distal end in the suprachoroidal space. Finally, the scleral incision is closed with multiple 10-0 nylon sutures and the conjunctiva is reapproximated with a 10-0 vicryl suture. Given the ab-externo approach with the conjunctival dissection, this procedure falls into the category of surgeries commonly referred to as blebless abexterno glaucoma surgery.
The novel SSD adopted by some of the authors in a recent pilot study consists of a silicon micro tube with length, interior and exterior diameter of 8.0 mm, 320 µm and 640 µm, respectively [12] .
In particular, a case series study of trabeculectomy versus SSD implant has been carried out on patients with open-angle glaucoma and morpho/functional worsening, despite maximal drug therapy [12] . The pilot study reported higher success rate in the patients with SSD implants at 12 months after surgery, in terms of less surgical complications and better post-operative IOP control.
In particular, the implant has given excellent results in terms of significative IOP reduction, allowing at the same time to keep a physiological depth of anterior chamber and low grade of intraocular inflammation. One case of early hypotony was noticed, however no excessive drainage has been observed later [12] . The simple geometry of the novel SSD allows to obtain a regular AH flow inside the device, and is considered to be responsible for the excellent percentage (90%) of complete success of the installations of the shunt obtained in the randomized comparative study [12] .
In the present work, the novel SSD is analysed numerically. In order to give a clear view of the actual installation of the device, a sketch of the anterior section of a human eye after installation of a drainage device is reported in Figure 2 , while the surgical installation stages of the novel SSD are reproduced in Figure 3 . The conjunctiva and Tenon's capsule were dissected from the superior limbus for approximately 4 clock hours to expose the sclera, and diathermy was applied to obtain a relatively dry field. A scleral incision at 4 mm from the limbus (1x4mm) was created with a crescent blade and the underlying choroid was exposed. A blunt spatula was inserted in the suprachoroidal space to create a real space until anterior chamber, creating a minimal cyclodialysis.
All the surgeries were not combined. The authors take into account modifications to the above geometry employed in the experiments: changes in the diameter of the shunt and a variable number of radial holes for AH outflow control are considered in the present simulations, as shown in Figure   4 .
THE MATHEMATICAL MODEL
The present mathematical model is based on the generalized approach for flow through porous media, that is very useful to study fluid dynamics problems where a free fluid and a porous medium are in contact. In this case, the porous medium is represented by ocular tissues, such as choroid and sclera, that are present in correspondence of the outflow section of the device implanted in the patient's eye, where the AH is drained. Therefore, the motion of the fluid inside the device is reproduced by solving free fluid flow equations, while the flow outside the device at the outlet section (interface between free fluid and porous medium) is reproduced by solving the porous medium flow equations. The present problem has been solved by using a single-domain approach for the device and for the surrounding tissues at the outlet section, opportunely setting the properties of the medium for the free fluid domain and for the porous domain. This procedure for treating interface problems can be easily employed by using the generalized porous medium model [23, 24, 26] . In fact, this model is a flexible tool, since it reduces to the Navier-Stokes equations for porosity and permeability values equal to one and infinite, respectively, allowing to reproduce the internal fluid dynamics of the two shunts described in the previous section. Instead, if porosity and permeability assumes finite values, the AH outflow through the porous tissues surrounding the outlet section of the devices in the suprachoroidal space is simulated.
The AH is considered as a Newtonian incompressible fluid with density of 1000 kg/m 3 and dynamic viscosity of ( ) 
Mass conservation equation
Momentum conservation equation
where the deviatoric stress is defined as: 
THE FULLY EXPLICIT CBS ALGORITHM
The Characteristic Based Split (CBS) algorithm used to solve numerically the generalized porous medium model reported in the previous section is based on the temporal discretization along characteristics, and spatial discretization obtained by employing the standard Galerkin finite element procedure [28, 29] .
The stable fully explicit CBS scheme employed in the present work has been validated for different thermo-fluid dynamics problems [23] [24] [25] [26] , and has been successfully applied in the present paper to effectively solve fluid flow in ocular drainage devices employed for the treatment of glaucoma. The fundamental steps of the explicit CBS scheme are presented in the following. After the temporal discretization along the characteristics, these steps can be written as:
Step 1: Intermediate velocity calculation ( )
where
The higher-order terms in the above equation appear from the discretization along the characteristics.
Step 2: Pressure calculation
Step 3: Velocity correction
The superscripts n+1 and n refer to the iterative procedure and not to actual time levels. 
where n N is the shape function at node n and n φ is the value of the generic variable φ at node n.
The spatial approximation applied to the 3D explicit CBS steps leads to the following final matrix form of the three steps:
Step 1: Intermediate velocity calculation
Where M is the mass matrix, C is the convection matrix, K d is the diffusion matrix, K u is the stabilization matrix obtained from higher-order terms, f d and f u are the boundary vectors from the momentum equation, K pr is the stiffness matrix, f pr is the boundary vector from the pressure equation, D is the gradient matrix. Details of all the terms presented in Equations (8)- (10) are given in references [28, 29] . The mass matrix is lumped using a standard row-summing approach, and the result is a fully matrix free procedure, particularly suitable to solve three-dimensional problems with a large number of grid elements. 
COMPUTATIONAL DOMAINS AND BOUNDARY CONDITIONS
In this section, the computational domains and the boundary conditions employed for the two drainage devices are shown. For the pre-processing stage, the commercial software Comsol
Multiphysics has been used. The first sub-section concerns the SOLX ® GMS [11] , while the second one concerns the novel SSD employed in a recent clinical study [12] .
SOLX ® Gold Micro Shunt (GMS)
The considered geometry is reported in Figure 1 . The data have been taken from reference [11] .
Since information on the exact position of holes and channels are not available, the geometry has been reproduced as shown in 
Novel Silicon Shunt Device (SSD)
The considered geometry is reported in Figure 4 , while the computational domain, together with the boundary conditions employed, are sketched in Figure 7 . Figure 6b shows a detail of the unstructured computational grid employed near the inflow section. The mesh is composed of 290,771 tetrahedral elements.
The same approach employed for the GMS to reproduce the human tissues has been used for the SSD. The inflow section of the microtube is subject to the AC pressure, while the surfaces of the porous tissues in correspondence of the outflow compartment are subject to the PSCS pressure. The AC pressure value considered in the simulations is 12 mmHg (1600 Pa), corresponding to the mean value measured by some of the present authors in a pilot study on patients after surgical insertion of the microtube [12] . The PSCS pressure value has been taken equal to 8.3 mmHg (1107 Pa), corresponding to a pressure difference between AC and PSCS of 3.7 mmHg, on the basis of the only experimental data on pressure difference available in the literature [16] . Wall boundary conditions, corresponding to zero value of the three components of the velocity vector, are imposed on all other surfaces of the computational domain.
This device, with very simple geometry, has given encouraging results in the recent pilot study conducted [12] . The configuration of the SSD employed in the clinical study had no radial holes, and it was a simple microtube of the same length and exterior diameter of the one studied here, with an interior diameter fixed to 320 µm. After the surgery, the microtube assumes a slight deformed shape, but the entity of this deformation is not expected to modify the present considerations. In this work, the presence of radial holes and the effect of changing the SSD diameter are analysed. 
RESULTS AND DISCUSSION
In this section, the numerical results obtained for AH flow driven by pressure difference in the SOLX ® GMS [11] and in the novel SSD employed in a recent pilot study [12] are presented here for the first time.
SOLX ® Gold Micro Shunt (GMS)
The velocity field of the AH inside the device, driven by the pressure difference between AC and ASCS, is shown in Figure 8 . From the analysis of the figure, it is evident that the velocity of AH at the microchannels is high compared to the inlet and outlet section. The device studied in the present work is able to obtain an AH drainage of 1.04 µl min , that is significantly smaller than normal AH production values for men and women, estimated at 2. mm/s, and AH flow is practically absent, as shown in Figure 10 . In this figure, the non-coloured zones are those where velocity is larger than 10 -5 mm/s. Since the AH does not move in an extended volume of the device, and the inflow and outflow through many holes is practically absent, the surrounding vessels in the AC and in the ASCS can easily penetrate the shunt through these holes,
with consequent possible problems of blockage and malfunction of the GMS. Another problem could be related to the fluid accumulated on the walls next to the microchannels, where the AH is 
Novel Silicon Shunt Device (SSD)
When the simple microtube is employed, a parabolic fluid flow is obtained in the shunt after a short entrance length. The maximum value of velocity approaches 1.7 mm/s, significantly larger than the velocity values for the GMS, therefore AH accumulation is not expected to occur. Furthermore, the regular cylindrical geometry is another favourable factor to avoid fluid accumulation. A volumetric flow rate (drainage from the AC to the PSCS) of 2.57 µl min is obtained, therefore significantly higher than the value corresponding to GMS and comparable to normal human values. If this value is considered too large by surgeons for patient needs, such as preoperative IOP values and other preoperative medical considerations (depth or inflammation of anterior chamber), a SSD with smaller diameter can be employed. In fact, a drainage of 1.92 µl min and of 1.52 µl min is obtained by reducing the diameter of the microtube to 280 µm and to 250 µm, respectively, as reported in Table 1 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The surgeons' concern, other than obtaining a lower postoperative IOP, is to keep an adequate anatomical morphology. The SCS is connected with the AC, therefore if the flow resistance was reduced (in order to obtain a higher outflow) a significative depth reduction of the AC could be caused, with several anatomical damage (as corneal endothelial cell loss, intraocular inflammation etc.). However, these effects have not been observed in any patient of the pilot study described in section 2 employing the SSD [12] . For this reason, the authors consider the maximum diameter of 320 µm, corresponding to the one employed in the pilot clinical study.
Therefore, surgeons can choose implants with smaller diameter in patients with a depth of the anterior chamber smaller than 2 mm or in patients with an increased risk of contact between shunt and corneal endothelium. When the risk of contact between endothelium and shunt increases, the choice of a less bulky shunt exposes the patient to less risk of corneal decompensation. For example, in hyperopic patients the axial length and the depth of the anterior chamber are lower than in normal eyes. In the case of high hyperopia, these values are even more reduced. Therefore, these patients would be better candidates for smaller shunts.
Among the modifications to the SSD, 100 µm diameter radial holes have been considered on the lateral surface of the microtube, to control the AH flow rate through the device. These holes are subject to the pressure of the PSCS. The results in terms of AH volumetric flow rate (drainage) through the SSD with different interior diameters and number of radial holes are reported in Table   1 . Surgeons could use this table to choose a device that better fit the patient specific needs. The use of radial holes is useful to manage the AH outflow with more flexibility with respect to the cases of simple microtubes. The devices employing three or six holes could be appropriate for patient needs,
given the calculated values of AH outflow reported in Table 1 , that are comparable to normal human values [32, 33] . On the other hand, Table 1 shows that the drainage calculated in presence of twelve holes is significantly larger than normal values for men and women.
This simple shunt can be a useful tool to be employed to control IOP, reducing post-operative complications due to accumulation of AH inside the device, thanks to its regular geometry. It also 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 obtained within the pilot study described in section 2 [12] .
CONCLUSIONS
In this paper, the generalized porous medium model has been employed to simulate the fluid dynamics in two ocular drainage devices, the SOLX® Gold Micro Shunt (GMS) and the novel microtubular Silicon Shunt Device (SSD), taking into account the presence of the surrounding porous tissues of the eye. The main outcomes of the present work are:
• The Aqueous Humor (AH) flow in the GMS encounters stagnation areas and low velocity regions, with consequent possible blockage and malfunction of the device;
• The novel SSD proposed by the authors allows to obtain an AH drainage comparable to normal human values, thanks to its regular microtubular geometry;
• The AH volumetric flow rate (drainage) has been calculated for different configurations of the SSD, by changing the diameter and/or employing a variable number of radial holes, in order to allow surgeons to choose the value that best fits patient specific needs, and to implant the most adequate shunt.
The authors believe that the present numerical simulation approach, based on the generalized porous medium model, represents a useful tool to study the fluid dynamics of ocular drainage devices and to design these shunts, reducing post-operative complications.
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